Search
for
Sort by
Research 61–90 of 757
- Resolution of Discoid Lupus Alopecia With Systemic Hydroxychloroquine and Topical Pimecrolimus Combination Therapy
- Alopecia areata in childhood
- Treatment of Frontal Fibrosing Alopecia
- Calcineurin/Nfatc1 signaling links skin stem cell quiescence to hormonal signaling during pregnancy and lactation
- Surgical Treatment of Vitiligo
- Morphea: progress to date and the road ahead
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Erosive pustular dermatosis (chronic atrophic dermatosis of the scalp and extremities)
- Menopause, skin and common dermatoses. Part 4: oral disorders
- Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Clinical pearls in dermatology 2018
- Contents
- Chronic Erythematous Plaques Around the Ears
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Janus Kinase inhibitors in dermatology: a review
- Calcineurin-based immunosuppression in renal transplantation : focus on efficacy, the role of steroids, and the cardiovascular risk
- Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes
- Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review
- Identifying novel strategies for treating human hair loss disorders: Cyclosporine A suppresses the Wnt inhibitor, SFRP1, in the dermal papilla of human scalp hair follicles
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- 16．微生物学研究室
- Cutaneous drug reactions
- 1379 Cyclosporin A suppresses TGF-β2 expression via calcineurin/NFAT pathway in human dermal papilla cells
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Dermatologic Adverse Events from Cancer Treatments
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Lupus erythematosus: systemic and cutaneous manifestations
- Taiwanese Dermatological Association consensus for the prevention and management of epidermal growth factor receptor tyrosine kinase inhibitor-related skin toxicities